Medical AI Data Enrichment

Clinically validated medical annotations and data enrichment for AI model training, with 99%+ accuracy across imaging, EHR, and pharmacovigilance data.

Overview

Medical AI Data Enrichment by Circulant Solutions Inc. is a clinically validated annotation and data enrichment service designed to power advanced AI research models for scientific discovery in the life sciences sector. Based in Pleasanton, California, Circulants serves Bio-Pharma companies and AI development teams that require high-quality, regulatory-ready training data to build diagnostic AI models, pharmacovigilance NLP systems, and drug discovery datasets.

Circulants leverages a hybrid AI-human approach, combining board-certified medical experts — including radiologists, pathologists, pharmacovigilance professionals, and clinical research specialists — with AI-assisted workflows to deliver annotations validated to 99%+ accuracy. This approach accelerates annotation delivery by 40–60% compared to traditional methods, while adhering to ISO 27001-certified and GxP-aligned processes that ensure compliance and regulatory readiness.

Key Capabilities

Medical Imaging Annotation: Expert labeling and segmentation of X-ray, CT, MRI, pathology slides, and ophthalmology images to fuel precise AI models for diagnostics and disease detection.
Clinical Text & EHR Annotation: Advanced processing of electronic health records and clinical notes, including Named Entity Recognition (NER) for key medical terms and automated ICD/CPT medical coding to support streamlined compliance and analysis.
Adverse Event Detection & Safety Signal Tagging: AI-driven identification and tagging of potential adverse events in patient data, enabling real-time safety signal monitoring and pharmacovigilance workflows.
Multimodal Data Integration: Seamless fusion of imaging, text, EHR, and other data sources into unified datasets, optimizing comprehensive AI training for holistic medical insights and predictive analytics.

Circulants' workflows are built to meet the rigorous standards of the Bio-Pharma industry, with ISO 27001 certification and GxP alignment ensuring that enriched datasets are suitable for regulatory submissions and accelerate clients' time-to-market.